DeBoer Douglas J, Moriello Karen A, Blum Jenifer L, Volk Lynn M
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA.
J Am Vet Med Assoc. 2003 May 1;222(9):1216-20. doi: 10.2460/javma.2003.222.1216.
To determine effects of lufenuron treatment in cats on the establishment and course of Microsporum canis infection following exposure to infected cats.
Experimental trial.
24 healthy juvenile domestic shorthair cats.
8 cats were given lufenuron PO (133 mg/cat/mo, equivalent to a dose of 100 to 130 mg/kg [45 to 59 mg/lb] at the beginning of the study and 25 to 35 mg/kg [11 to 16 mg/lb] at the end of the study), and 8 were given lufenuron SC (40 mg every 6 months). The remaining 8 were used as untreated control cats. After 4 months, cats were challenged by the introduction of cats with mild, experimentally induced M canis infection into the rooms where cats were housed. Extent of resulting infections in the naïve cats was monitored for 22 weeks by physical examination and fungal culture.
All lufenuron-treated and control cats became infected with M canis. Cats treated with lufenuron had significantly lower infection scores, compared with control cats, during the early weeks following exposure, and there was a more prolonged initial progression phase of the infection. Once infections reached peak intensity, they resolved over similar periods in lufenuron-treated and control cats.
Results suggested that oral or SC administration of lufenuron to cats, at the dosages used and under the conditions of this study, did not prevent establishment of dermatophytosis following exposure to infected cats. Infection was established more slowly among cats treated with lufenuron, but once established, infection resolved in approximately the same amount of time in lufenuron-treated as in control cats.
确定在接触受感染猫后,用氯芬奴隆治疗猫对犬小孢子菌感染的建立及病程的影响。
实验性试验。
24只健康的幼年家养短毛猫。
8只猫口服氯芬奴隆(133毫克/猫/月,在研究开始时相当于100至130毫克/千克[45至59毫克/磅],在研究结束时相当于25至35毫克/千克[11至16毫克/磅]),8只猫皮下注射氯芬奴隆(每6个月40毫克)。其余8只作为未治疗的对照猫。4个月后,通过将患有轻度实验性诱导犬小孢子菌感染的猫引入猫居住的房间来对猫进行攻毒。通过体格检查和真菌培养对未感染猫中由此产生的感染程度进行22周的监测。
所有接受氯芬奴隆治疗的猫和对照猫均感染了犬小孢子菌。与对照猫相比,接受氯芬奴隆治疗的猫在接触后的最初几周内感染评分显著较低,且感染的初始进展阶段更长。一旦感染达到峰值强度,在接受氯芬奴隆治疗的猫和对照猫中,感染在相似的时间段内消退。
结果表明,在本研究的所用剂量和条件下,对猫口服或皮下注射氯芬奴隆并不能预防接触受感染猫后皮肤癣菌病的发生。在接受氯芬奴隆治疗的猫中,感染的建立较为缓慢,但一旦建立,接受氯芬奴隆治疗的猫与对照猫的感染消退时间大致相同。